These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 30748002)
1. Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma. Lee NCJ; Kelly JR; An Y; Park HS; Judson BL; Burtness BA; Husain ZA Cancer; 2019 Jun; 125(12):2018-2026. PubMed ID: 30748002 [TBL] [Abstract][Full Text] [Related]
2. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer. David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546 [TBL] [Abstract][Full Text] [Related]
3. The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database. Gootee J; Patel M; Aurit S; Silberstein P Clin Transl Oncol; 2020 Dec; 22(12):2264-2274. PubMed ID: 32440914 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis. Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410 [TBL] [Abstract][Full Text] [Related]
5. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer. Zumsteg ZS; Kim S; David JM; Yoshida EJ; Tighiouart M; Shiao SL; Scher K; Mita A; Sherman EJ; Lee NY; Ho AS Cancer; 2017 May; 123(9):1555-1565. PubMed ID: 28001302 [TBL] [Abstract][Full Text] [Related]
6. Proton radiotherapy and treatment delay in head and neck squamous cell carcinoma. Jin MC; Harris JP; Sabolch AN; Gensheimer M; Le QT; Beadle BM; Pollom EL Laryngoscope; 2020 Nov; 130(11):E598-E604. PubMed ID: 31837165 [TBL] [Abstract][Full Text] [Related]
7. Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis. Kirke DN; Qureshi MM; Kamran SC; Ezzat W; Jalisi S; Salama A; Everett PC; Truong MT Head Neck; 2018 Jun; 40(6):1174-1184. PubMed ID: 29417687 [TBL] [Abstract][Full Text] [Related]
8. Factors Associated With the Choice of Radiation Therapy Treatment Facility in Head and Neck Cancer. Sullivan CB; Al-Qurayshi Z; Anderson CM; Seaman AT; Pagedar NA Laryngoscope; 2021 May; 131(5):1019-1025. PubMed ID: 32846018 [TBL] [Abstract][Full Text] [Related]
9. The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly. Haehl E; Rühle A; Klink R; Kalckreuth T; Sprave T; Gkika E; Zamboglou C; Meiß F; Grosu AL; Nicolay NH Radiat Oncol; 2021 Jun; 16(1):105. PubMed ID: 34118984 [TBL] [Abstract][Full Text] [Related]
10. Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck - results from an unselected cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer". Schüttrumpf L; Marschner S; Scheu K; Hess J; Rietzler S; Walch A; Baumeister P; Kirchner T; Ganswindt U; Zitzelsberger H; Belka C; Maihoefer C Radiat Oncol; 2020 Jan; 15(1):7. PubMed ID: 31906998 [TBL] [Abstract][Full Text] [Related]
11. Surgery with postoperative radiotherapy for pN2 head and neck squamous cell carcinoma. Joo YH; Cho KJ; Park JO; Nam IC; Kim CS; Cho HJ; Kim MS Acta Otolaryngol; 2013 Oct; 133(10):1104-9. PubMed ID: 24032573 [TBL] [Abstract][Full Text] [Related]
12. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age. Chen MM; Colevas AD; Megwalu U; Divi V Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant radiotherapy is not supported in patients with verrucous carcinoma of the oral cavity. Mohan S; Pai SI; Bhattacharyya N Laryngoscope; 2017 Jun; 127(6):1334-1338. PubMed ID: 28150306 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer. Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536 [TBL] [Abstract][Full Text] [Related]
15. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer. Graboyes EM; Garrett-Mayer E; Ellis MA; Sharma AK; Wahlquist AE; Lentsch EJ; Nussenbaum B; Day TA Cancer; 2017 Dec; 123(24):4841-4850. PubMed ID: 28841234 [TBL] [Abstract][Full Text] [Related]
16. Postoperative radiation performed at the same surgical facility associated with improved overall survival in oral cavity squamous cell carcinoma. Amini A; Stokes WA; Jones BL; Sampath S; Kang RS; Gernon TJ; Maghami EG; Massarelli E; Bradley CJ; Karam SD Head Neck; 2019 Jul; 41(7):2299-2308. PubMed ID: 30737961 [TBL] [Abstract][Full Text] [Related]
17. Patterns of care and outcomes of adjuvant therapy for high-risk head and neck cancer after surgery. Osborn VW; Givi B; Rineer J; Roden D; Sheth N; Lederman A; Katsoulakis E; Hu K; Schreiber D Head Neck; 2018 Jun; 40(6):1254-1262. PubMed ID: 29451961 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma. Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant radiation for positive margins in adult head and neck sarcomas is associated with improved survival: Analysis of the National Cancer Database. Cannon RB; Kull AJ; Carpenter PS; Francis S; Buchmann LO; Monroe MM; Lloyd S; Hitchcock YJ; Cannon D; Weis JR; Houlton JJ; Hunt JP Head Neck; 2019 Jun; 41(6):1873-1879. PubMed ID: 30652375 [TBL] [Abstract][Full Text] [Related]
20. Single-Arm Phase 2 Trial of Elective Nodal Dose Reduction for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck. Maguire PD; Neal CR; Hardy SM; Schreiber AM Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1210-1216. PubMed ID: 29452770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]